3-per, 2-trt designs and estimation of intra-subj. variance [RSABE / ABEL]

posted by Dr_Dan  – Germany, 2013-08-13 12:11 (4700 d 17:43 ago) – Posting: # 11265
Views: 12,826

Hi ElMaestro
Interesting considerations. However, I do not see the advantage of a TRR/RTR/RRT xover design. What do you think about TRT vs RTR? In this case you also have a 3-per, 2-trt design but you can estimate the intrasubject variability for the Test product, right?
Kind regards
Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
181 visitors (0 registered, 181 guests [including 21 identified bots]).
Forum time: 05:55 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5